English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [2303]
News [5292]
Articles [130]
Editorials [4]
Conferences [158]
elearning [13]
Study indicates that cancer patients gain important benefits from genome-matched treatments
Study indicates that cancer patients gain important benefits from genome-matched treatments
Microbiome researchers challenge the state of the art in colon cancer biomarker discovery
Microbiome researchers challenge the state of the art in colon cancer biomarker discovery
Researchers identify biomarkers in blood to predict liver cancer
Researchers identify biomarkers in blood to predict liver cancer
FDA clearance announced for IND application for first-in-class PRAME-targeted TCR NK cell therapy for haematological malignancies
FDA clearance announced for IND application for first-in-class PRAME-targeted TCR NK cell therapy for...
UK’s NICE recommends continued access to tisagenlecleucel for children and young adults with ALL
UK’s NICE recommends continued access to tisagenlecleucel for children and young adults with ALL
Positive CHMP opinion establishes amivantamab as a new treatment option in the first-line treatment of EGFR exon 20 insertion-mutated NSCLC
Positive CHMP opinion establishes amivantamab as a new treatment option in the first-line treatment of EGFR exon...
FDA approves tisotumab vedotin-tftv for recurrent or metastatic cervical cancer
FDA approves tisotumab vedotin-tftv for recurrent or metastatic cervical cancer
Targeting specific protein regions offers a new treatment approach in medulloblastoma
Targeting specific protein regions offers a new treatment approach in medulloblastoma
NICE recommends dabrafenib plus trametinib combo for treating BRAF V600E mutation-positive brain tumours
NICE recommends dabrafenib plus trametinib combo for treating BRAF V600E mutation-positive brain tumours
Liver cancer: Molecular signalling pathway of tumour development decoded
Liver cancer: Molecular signalling pathway of tumour development decoded
<1...4344454647...530>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top